Dr. Federica Crivellente
Dr Federica Crivellente is Research Investigator, Biomarkers & Applied Immunology Laboratory at Aptuit, Verona, Italy. Prior to joining Aptuit as a Research Investigator in 2010, Dr Crivellente was Clinical Pathology Manager in GlaxoSmthKline (from 2001). Starting with a degree in Biology from the University of Padua, she completed her PhD (1996 -1999), supervised by Prof. Franco Tagliaro, at the Dept. of Public Health and Community Medicine, Unit of Forensic Medicine, University of Verona, investigating the role of carbohydrate deficient transferrin (CDT) as a marker of chronic alcohol abuse in humans and setting up a method for its determination by mean of capillary electrophoresis. Following this, she completed 1 and ½ year post-doctoral fellowships on the development of new methodologies for forensic DNA analysis by capillary electrophoresis with Prof. Bruce McCord at Ohio University, Ohio, USA (2000-2001). She then joined GSK and earned a Specialization in Biochemistry and Clinical Chemistry at the University of Brescia in 2002. Dr Crivellente has a wide experience in safety biomarker validation by mean of different analytical methods and Clinical Pathology data analysis and interpretation in General Toxicology studies (both GLP and non-GLP); she acted also a Safety Assessment Project Representative and was involved in many GSK worldwide projects on safety issues. She is a Member of the American Society of Veterinary Clinical Pathology and is a co-author of about 30 full publications in international journals/books.